JP2019520415A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520415A5
JP2019520415A5 JP2019500810A JP2019500810A JP2019520415A5 JP 2019520415 A5 JP2019520415 A5 JP 2019520415A5 JP 2019500810 A JP2019500810 A JP 2019500810A JP 2019500810 A JP2019500810 A JP 2019500810A JP 2019520415 A5 JP2019520415 A5 JP 2019520415A5
Authority
JP
Japan
Prior art keywords
quinoline
difluorophenyl
fluoro
aminopiperidin
methylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019500810A
Other languages
English (en)
Japanese (ja)
Other versions
JP6967577B2 (ja
JP2019520415A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041694 external-priority patent/WO2018013676A1/en
Publication of JP2019520415A publication Critical patent/JP2019520415A/ja
Publication of JP2019520415A5 publication Critical patent/JP2019520415A5/ja
Priority to JP2021173304A priority Critical patent/JP2022028675A/ja
Application granted granted Critical
Publication of JP6967577B2 publication Critical patent/JP6967577B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019500810A 2016-07-14 2017-07-12 ソマトスタチンモジュレーターとその使用 Active JP6967577B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021173304A JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662362493P 2016-07-14 2016-07-14
US62/362,493 2016-07-14
US201662411338P 2016-10-21 2016-10-21
US62/411,338 2016-10-21
PCT/US2017/041694 WO2018013676A1 (en) 2016-07-14 2017-07-12 Somatostatin modulators and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021173304A Division JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Publications (3)

Publication Number Publication Date
JP2019520415A JP2019520415A (ja) 2019-07-18
JP2019520415A5 true JP2019520415A5 (enExample) 2021-09-30
JP6967577B2 JP6967577B2 (ja) 2021-11-17

Family

ID=60941935

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019500810A Active JP6967577B2 (ja) 2016-07-14 2017-07-12 ソマトスタチンモジュレーターとその使用
JP2021173304A Ceased JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021173304A Ceased JP2022028675A (ja) 2016-07-14 2021-10-22 ソマトスタチンモジュレーターとその使用

Country Status (24)

Country Link
US (6) US9896432B2 (enExample)
EP (2) EP4163276A1 (enExample)
JP (2) JP6967577B2 (enExample)
KR (2) KR102324042B1 (enExample)
CN (2) CN109715612B (enExample)
AU (2) AU2017296392B2 (enExample)
CA (1) CA3030423A1 (enExample)
DK (1) DK3484865T3 (enExample)
ES (1) ES2931472T3 (enExample)
HR (1) HRP20221279T1 (enExample)
HU (1) HUE060182T2 (enExample)
IL (1) IL264178B2 (enExample)
LT (1) LT3484865T (enExample)
MX (1) MX390120B (enExample)
NZ (1) NZ750174A (enExample)
PL (1) PL3484865T3 (enExample)
PT (1) PT3484865T (enExample)
RS (1) RS63776B1 (enExample)
SG (1) SG11201900349VA (enExample)
SM (1) SMT202200465T1 (enExample)
TW (1) TWI789355B (enExample)
UA (1) UA125393C2 (enExample)
WO (1) WO2018013676A1 (enExample)
ZA (1) ZA201900317B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3484865T3 (pl) 2016-07-14 2023-01-09 Crinetics Pharmaceuticals, Inc. Modulatory somatostatyny i ich zastosowania
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
WO2019023278A1 (en) 2017-07-25 2019-01-31 Crinetics Pharmaceuticals, Inc. MODULATORS OF SOMATOSTATIN AND USES THEREOF
CA3088658A1 (en) 2018-01-17 2019-07-25 Crinetics Pharmaceuticals, Inc. Process of making somatostatin modulators
WO2019157458A1 (en) * 2018-02-12 2019-08-15 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3807248A4 (en) * 2018-05-29 2021-10-27 Council of Scientific and Industrial Research BICYCLIC TOPOISOMERASE I INHIBITOR COMPOUNDS, THEIR PREPARATION AND USE
JP7431813B2 (ja) 2018-09-18 2024-02-15 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターとその使用
JP2022540922A (ja) * 2019-07-17 2022-09-20 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターの結晶形態
TWI841768B (zh) * 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
SMT202500315T1 (it) * 2020-09-09 2025-11-10 Crinetics Pharmaceuticals Inc Formulazioni di un modulatore della somatostatina
CN117043149A (zh) 2021-02-17 2023-11-10 克林提克斯医药股份有限公司 促生长素抑制素调节剂的结晶形式
CA3216457A1 (en) * 2021-05-25 2022-12-01 Ajay Madan Uses of a somatostatin modulator for the treatment of disease
EP4378971A4 (en) 2021-09-28 2024-11-20 Denka Company Limited CHLOROPRENE BLOCK COPOLYMER, LATEX, LATEX COMPOSITION AND RUBBER COMPOSITION
AU2023207068A1 (en) * 2022-01-11 2024-07-11 Crinetics Pharmaceuticals, Inc. Uses of a somatostatin modulator for the treatment of carcinoid syndrome
EP4547654A1 (en) 2022-06-10 2025-05-07 Assia Chemical Industries Ltd. Solid state forms of paltusotine and process for preparation thereof
PE20251882A1 (es) * 2022-10-28 2025-07-22 Basecamp Bio Inc Agonistas del receptor de la somatostatina 2 y usos de estos
US20240254106A1 (en) 2022-12-13 2024-08-01 Crinetics Pharmaceuticals, Inc. Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof
KR20250162795A (ko) 2023-03-28 2025-11-19 크리네틱스 파마슈티칼스, 인크. 간 기능장애가 있는 환자에게 팔투소틴을 투여하기 위한 조성물 및 방법
WO2025111318A1 (en) * 2023-11-22 2025-05-30 Crinetics Pharmaceuticals, Inc. Somatostatin subtype receptor 3 (sstr3) agonists and uses thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1035154A (en) 1910-05-16 1912-08-13 Ernest G Clark Machine for rectifying perforated music and masters.
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
EP1451156A4 (en) 2001-11-27 2005-05-25 Merck & Co Inc 4-AMINOCHINOLINVERBINDUNGEN
WO2003066055A1 (en) * 2002-02-04 2003-08-14 F. Hoffmann-La Roche Ag Quinoline derivatives as npy antagonists
US7767817B2 (en) 2003-09-05 2010-08-03 Binghe Wang Water soluble boronic acid fluorescent reporter compounds and methods of use thereof
EP1773343A4 (en) * 2004-07-13 2009-05-13 Glaxo Group Ltd ANTIBACTERIAL AGENTS
US20060183763A1 (en) 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
CN101365439B (zh) 2005-12-05 2012-12-26 克塞诺波特公司 左旋多巴前体药物甲磺酸盐、其组合物及其用途
EP1991540A1 (en) 2006-02-21 2008-11-19 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
WO2007103554A1 (en) 2006-03-08 2007-09-13 Amgen Inc. Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
AU2007309708A1 (en) * 2006-03-13 2008-05-02 Merck Sharp & Dohme Corp. Somatostatin agonists
MX2011002367A (es) 2008-09-02 2011-04-04 Novartis Ag Inhibidores de cinasa biciclicos.
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
BR112013002182B8 (pt) * 2010-07-30 2023-02-28 Oncotherapy Science Inc Compostos derivados de quinolina, composição farmacêutica, inibidor de melk, agente modulador de expressão de melk, agente antitumor, agente terapêutico e/ou preventivo para uma doença que envolve a superexpressão de melk contendo os mesmos e uso dos referidos compostos
AU2012258977A1 (en) 2011-05-23 2014-01-16 Imago Pharmaceuticals, Inc. Inhibitors of LRRK2 kinase activity
US8871756B2 (en) 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
DE102011113749A1 (de) 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
WO2013050996A2 (en) 2011-10-05 2013-04-11 Mapi Pharma Ltd. Process and intermediates for the preparation of substituted 2-arylthiazole carboxylic acids
EP2871179A4 (en) * 2012-07-03 2016-03-16 Ono Pharmaceutical Co CONNECTION WITH AGONISTIC EFFECT ON THE SOMATOSTATIN RECEPTOR AND ITS USE FOR MEDICAL PURPOSES
PE20151203A1 (es) * 2012-10-16 2015-08-31 Janssen Pharmaceutica Nv MODULADORES DE QUINOLINILO UNIDOS A FENILO DE ROR-GAMMA-t
TWI628175B (zh) 2013-09-30 2018-07-01 日商小野藥品工業股份有限公司 具有體抑素受體致效活性的化合物及其醫藥用途
JO3805B1 (ar) 2013-10-10 2021-01-31 Araxes Pharma Llc مثبطات كراس جي12سي
CA2943643A1 (en) 2014-03-24 2015-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound
WO2016049568A1 (en) 2014-09-25 2016-03-31 Araxes Pharma Llc Methods and compositions for inhibition of ras
US9902703B2 (en) 2015-07-01 2018-02-27 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
HK1255034A1 (zh) 2015-07-01 2019-08-02 Crinetics Pharmaceuticals, Inc. 生长抑素调节剂及其用途
EP3889145B1 (en) 2015-12-17 2024-02-21 Merck Patent GmbH 8-cyano-5-piperidino-quinolines as tlr7/8 antagonists and their uses for treating immune disorders
US10597393B2 (en) 2016-07-07 2020-03-24 Plantex Ltd. Solid state forms of Palbociclib dimesylate
PL3484865T3 (pl) * 2016-07-14 2023-01-09 Crinetics Pharmaceuticals, Inc. Modulatory somatostatyny i ich zastosowania
CA3088658A1 (en) 2018-01-17 2019-07-25 Crinetics Pharmaceuticals, Inc. Process of making somatostatin modulators
JP7431813B2 (ja) 2018-09-18 2024-02-15 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターとその使用
JP2022540922A (ja) 2019-07-17 2022-09-20 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンモジュレーターの結晶形態
SMT202500315T1 (it) 2020-09-09 2025-11-10 Crinetics Pharmaceuticals Inc Formulazioni di un modulatore della somatostatina

Similar Documents

Publication Publication Date Title
JP2019520415A5 (enExample)
HRP20221279T1 (hr) Modulatori somatostatina i njihove uporabe
CA2628490A1 (en) 5-lipoxygenase-activating protein (flap) inhibitors
US9051310B2 (en) Nicotinamide derivative or salt thereof
KR101825543B1 (ko) 유기 광전자 소자 및 표시장치
JP2015502967A5 (enExample)
EP3392236B1 (en) Method for producing aromatic amide derivative
EP3041841B1 (en) Triazolopyridine compounds, compositions and methods of use thereof
US5843973A (en) Thiazolidinone compounds and composition for angina pectoris comprising the compounds as an active ingredient
JP3058945B2 (ja) N−(3,3−ジ置換アクリロイル)ピペラジン誘導体
JPH0770072A (ja) チオウレア誘導体
Das Generated Tables by BIVNOR
KR20250088869A (ko) 유기 광전자 소자용 조성물, 유기 광전자 소자 및 표시 장치
Cee 3a roAi. 1937-1938
TW200418858A (en) Carbapenem derivatives
JPH08217765A (ja) チアゾリジノン化合物
JP2006045153A (ja) カルバペネム誘導体を含有する医薬
JP2004262923A (ja) カルバペネム誘導体